Everpar Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$595K Buy
5,756
+83
+1% +$7.41K 0.17% 127
2026
Q1
$407K Buy
5,673
+528
+10% +$40.7K 0.14% 158
2025
Q4
$408K Buy
5,145
+122
+2% +$9.62K 0.15% 151
2025
Q3
$379K Sell
5,023
-65
-1% -$4.46K 0.15% 159
2025
Q2
$351K Sell
5,088
-393
-7% -$25.8K 0.16% 175
2025
Q1
$371K Buy
+5,481
New +$328K 0.2% 142
2024
Q4
Sell
-4,338
Closed -$273K 268
2024
Q3
$273K Sell
4,338
-818
-16% -$47.7K 0.14% 203
2024
Q2
$305K Buy
+5,156
New +$323K 0.15% 186

Other funds holding CVS

Everpar Advisors's CVS Position: Q2 2026 in Review

Everpar Advisors increased its CVS Health (CVS) stake by 1.5% in Q2 2026, buying an estimated $7.41K and bringing the position to 5,756 shares worth $595K. The position accounts for 0.17% of the portfolio, ranked #127.

Everpar Advisors first reported a position in CVS in Q2 2024 and has held it in 8 quarters since. 348 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Everpar Advisors held 5,756 shares of CVS Health worth $595K as of Q2 2026.
  • Everpar Advisors bought 83 CVS Health shares in Q2 2026, an estimated $7.41K.
  • CVS Health made up 0.17% of Everpar Advisors's portfolio in Q2 2026, its #127 holding.
  • Everpar Advisors first reported a position in CVS Health in Q2 2024 and has held it in 8 quarters since.
  • 348 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.